Pharmaceuticals
Japan's Takeda aims to sell vaccines in U.S., targeting dengue first
Drugmaker hopes to break into market dominated by American and European players
Pharmaceuticals
Pharmaceuticals
American clinical trials in China questioned by U.S. lawmakers
House members cite risks of intellectual property theft and forced use of Uyghurs
Pharmaceuticals
Kobayashi Pharma to exit red yeast rice business amid health scandal
Number of deaths linked to supplements reaches 107
Health Care
Japan's Terumo sets up $75m U.S. venture capital fund
Medical equipment maker aims to invest in advanced treatment startups
Pharmaceuticals
Japan's Shionogi seeks China approval for superbug-fighting antibiotic
Cefiderocol drives drugmaker's overseas sales in U.S. and Europe
Pharmaceuticals
Singapore gets Big Pharma rush to invest in plants for aging region
Pfizer, AstraZeneca and Novartis to expand production for cancer and other drugs
Pharmaceuticals
Takeda to cut 1,000 U.S. jobs and close San Diego hub
Japanese drugmaker streamlines operations as ADHD therapy patent expires
Coronavirus
Japanese researchers eye COVID treatment derived from stem cells
Immunotherapy creates killer T cells that detect coronavirus markers
Pharmaceuticals
Eisai shares fall 13% as EU rejects Alzheimer's drug
High expectations take a hit as regulator fails to follow the U.S., Japan and China
Pharmaceuticals
Alzheimer's drug from Eisai and Biogen rejected in Europe
Leqembi seen offering small improvement while risking bleeding in brain
Pharmaceuticals
Japan's Eisai eyes blood test for Alzheimer's drug eligibility
Drugmaker looks to lower hurdles to use of potential blockbuster treatment
Pharmaceuticals
Activist investor Oasis buys 5% stake in scandal-hit Kobayashi Pharma
Hong Kong fund becomes 4th-largest shareholder in Japanese drugmaker
Pharmaceuticals
Japan's Taisho Pharma faces claim over buyout price from Curi RMB, Oasis
Investment funds say tender offer undercut interest of minority shareholders
IPO
Bain-backed Emcure Pharma's $234m India IPO draws $11bn in bids
Company strong in women's health draws subscriptions nearly 68 times offer amount
Supply Chain
Japan to subsidize antibiotics supply chain to reduce China exposure
Production of active ingredients has moved abroad for cost reasons
Pharmaceuticals
Blackstone targets health care sector in Japan push
Alinamin Pharma sale is latest in string of deals by U.S. private equity
Business deals
Blackstone to sell Japan supplement maker Alinamin to MBK for $2.2bn
OTC drugmaker focuses on overseas growth amid saturated domestic market
Pharmaceuticals
Japan's Eisai aims for 2030 U.S. release of new Alzheimer's drug
Pharma hopes to use in combination with lecanemab for greater effectiveness
Pharmaceuticals
Japan's Kobayashi Pharma reveals 76 more deaths possibly linked to supplement
Health minister vows action as suspected fatalities jump from previously reported five
Pharmaceuticals
Takeda draws investor scrutiny for CEO's $93m 10-year payout
Japan pharma maker underperformed under Weber, critics say
Pharmaceuticals
After U.S. job cuts, Sumitomo Pharma eyes layoffs in Japan
New president stresses downsizing to turn around earnings slump
Pharmaceuticals
Novo Nordisk's Wegovy weight-loss drug approved in China
But drugmaker faces patent fight and has limited capacity to boost output
Companies
China's Fosun to buy out remaining shares of Henlius Biotech
Conglomerate's deal values Hong Kong-listed drugmaker at $1.7bn
Obituaries
Takeda Pharmaceutical's ex-chairman Kunio Takeda dies at 84
Chief from founding family once said, 'Non-owner president cannot achieve real reform'
Business deals
Kirin to purchase Japanese skin care company Fancl for $1.3bn
Brewer to launch tender offer in bid to bolster supplements business